Cyclopharm Ltd (CYC) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.241x

Based on the latest financial reports, Cyclopharm Ltd (CYC) has a cash flow conversion efficiency ratio of -0.241x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-7.69 Million ≈ $-5.44 Million USD) by net assets (AU$31.86 Million ≈ $22.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Cyclopharm Ltd for the company's overall valuation and market capitalisation.

Cyclopharm Ltd - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Cyclopharm Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Cyclopharm Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cyclopharm Ltd ranked by their cash flow conversion efficiency. Explore cash flow quality index of Cyclopharm Ltd to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Cengild Medical Berhad KLSE:0243	0.039x
Haesung Optics Co. Ltd KQ:076610	-0.009x
EDM Resources Inc V:EDM	-0.067x
Mccoy Global Inc TO:MCB	0.095x
Dae Hyun KO:016090	0.028x
YNH Property Bhd KLSE:3158	0.056x
TWL Holdings Bhd KLSE:7079	-0.043x
Reading International Inc NASDAQ:RDI	-0.136x

Annual Cash Flow Conversion Efficiency for Cyclopharm Ltd (2005–2025)

The table below shows the annual cash flow conversion efficiency of Cyclopharm Ltd from 2005 to 2025. View Cyclopharm Ltd (CYC) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	AU$27.11 Million ≈ $19.18 Million	AU$-17.33 Million ≈ $-12.26 Million	-0.639x	-117.21%
2024-12-31	AU$42.73 Million ≈ $30.23 Million	AU$-12.57 Million ≈ $-8.90 Million	-0.294x	-31.89%
2023-12-31	AU$32.26 Million ≈ $22.83 Million	AU$-7.20 Million ≈ $-5.09 Million	-0.223x	-43.52%
2022-12-31	AU$36.54 Million ≈ $25.85 Million	AU$-5.68 Million ≈ $-4.02 Million	-0.155x	-310.91%
2021-12-31	AU$43.07 Million ≈ $30.47 Million	AU$-1.63 Million ≈ $-1.15 Million	-0.038x	+92.75%
2020-12-31	AU$17.12 Million ≈ $12.11 Million	AU$-8.93 Million ≈ $-6.32 Million	-0.522x	-2375.37%
2019-12-31	AU$23.20 Million ≈ $16.42 Million	AU$-489.34K ≈ $-346.24K	-0.021x	+67.59%
2018-12-31	AU$17.02 Million ≈ $12.04 Million	AU$-1.11 Million ≈ $-783.51K	-0.065x	-64.56%
2017-12-31	AU$17.25 Million ≈ $12.21 Million	AU$-682.12K ≈ $-482.64K	-0.040x	-175.26%
2016-12-31	AU$12.46 Million ≈ $8.82 Million	AU$654.79K ≈ $463.31K	0.053x	-83.43%
2015-12-31	AU$13.10 Million ≈ $9.27 Million	AU$4.15 Million ≈ $2.94 Million	0.317x	-44.96%
2014-12-31	AU$7.76 Million ≈ $5.49 Million	AU$4.47 Million ≈ $3.16 Million	0.576x	+198.54%
2013-12-31	AU$3.66 Million ≈ $2.59 Million	AU$706.71K ≈ $500.04K	0.193x	+715.72%
2012-12-31	AU$15.61 Million ≈ $11.04 Million	AU$369.29K ≈ $261.29K	0.024x	-38.69%
2011-12-31	AU$14.60 Million ≈ $10.33 Million	AU$563.63K ≈ $398.80K	0.039x	+684.06%
2010-12-31	AU$13.77 Million ≈ $9.74 Million	AU$-90.96K ≈ $-64.36K	-0.007x	-102.49%
2009-12-31	AU$13.93 Million ≈ $9.86 Million	AU$3.69 Million ≈ $2.61 Million	0.265x	+132.81%
2008-12-31	AU$13.06 Million ≈ $9.24 Million	AU$1.49 Million ≈ $1.05 Million	0.114x	+472.02%
2007-12-31	AU$7.34 Million ≈ $5.20 Million	AU$146.10K ≈ $103.37K	0.020x	+100.96%
2006-12-31	AU$-566.06K ≈ $-400.52K	AU$1.17 Million ≈ $827.14K	-2.065x	-1691.99%
2005-12-31	AU$11.34 Million ≈ $8.02 Million	AU$1.47 Million ≈ $1.04 Million	0.130x	--

About Cyclopharm Ltd

AU:CYC Australia Medical Devices

Market Cap

$41.81 Million

AU$59.10 Million AUD

Market Cap Rank

#22670 Global

#820 in Australia

Share Price

AU$0.47

Change (1 day)

-2.08%

52-Week Range

AU$0.46 - AU$1.23

All Time High

AU$3.26